CH573896A5 - - Google Patents

Info

Publication number
CH573896A5
CH573896A5 CH1097771A CH1097771A CH573896A5 CH 573896 A5 CH573896 A5 CH 573896A5 CH 1097771 A CH1097771 A CH 1097771A CH 1097771 A CH1097771 A CH 1097771A CH 573896 A5 CH573896 A5 CH 573896A5
Authority
CH
Switzerland
Application number
CH1097771A
Inventor
J F Bagli
T Bogri
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of CH573896A5 publication Critical patent/CH573896A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/215Saturated compounds having only one carboxyl group and containing keto groups containing singly bound oxygen containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1097771A 1970-07-30 1971-07-26 CH573896A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5970270A 1970-07-30 1970-07-30

Publications (1)

Publication Number Publication Date
CH573896A5 true CH573896A5 (de) 1976-03-31

Family

ID=22024690

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1097771A CH573896A5 (de) 1970-07-30 1971-07-26

Country Status (7)

Country Link
US (1) US3671570A (de)
CA (1) CA972749A (de)
CH (1) CH573896A5 (de)
DE (1) DE2137811C3 (de)
FR (1) FR2100971B1 (de)
NL (1) NL7110590A (de)
SE (1) SE375984B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903299A (en) * 1970-05-27 1975-09-02 May & Baker Ltd Pharmaceutical compositions containing cyclopentane derivatives
US3907998A (en) * 1971-06-28 1975-09-23 Ayerst Mckenna & Harrison Methods for relieving bronchial spasm with 9,15-dioxygenated prostanoic and prost-13-enoic acids and the like
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US3974213A (en) * 1972-07-13 1976-08-10 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
CA1018970A (en) * 1972-10-27 1977-10-11 American Home Products Corporation 15-substituted prostanoic acids
US3972917A (en) * 1972-10-27 1976-08-03 American Home Products Corporation 11-Deoxy 15-methyl prostaglandin E1
US4152527A (en) * 1972-11-08 1979-05-01 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals
US4036832A (en) * 1974-07-03 1977-07-19 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
GB1499253A (en) * 1975-02-14 1978-01-25 Upjohn Co Prostaglandins
US4054741A (en) * 1975-06-27 1977-10-18 Ayerst Mckenna & Harrison Ltd. Derivatives of prostanoic acid
NZ561414A (en) * 2005-03-04 2010-10-29 Sucampo Ag Method and composition for treating peripheral vascular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1097533A (en) * 1965-08-16 1968-01-03 Upjohn Co Prostanoic acid derivatives
GB1198071A (en) * 1966-08-09 1970-07-08 George Erich Just Improvements in or relating to Prostaglandin Analogues and the Manufacture thereof

Also Published As

Publication number Publication date
FR2100971A1 (de) 1972-03-24
DE2137811C3 (de) 1980-10-30
FR2100971B1 (de) 1975-02-07
DE2137811A1 (de) 1972-02-03
CA972749A (en) 1975-08-12
NL7110590A (de) 1972-02-01
US3671570A (en) 1972-06-20
DE2137811B2 (de) 1980-02-28
SE375984B (de) 1975-05-05

Similar Documents

Publication Publication Date Title
ATA96471A (de)
AU1146470A (de)
AU2044470A (de)
AU1473870A (de)
AU1326870A (de)
AU2085370A (de)
AU2017870A (de)
AU1833270A (de)
AU1716970A (de)
AU1517670A (de)
AU1336970A (de)
AU1591370A (de)
AU1064870A (de)
AU2144270A (de)
AU2131570A (de)
AU2130770A (de)
AU1277070A (de)
AU1328670A (de)
AU1247570A (de)
AU1343870A (de)
AU2130570A (de)
AU2119370A (de)
AU1235770A (de)
AU1581370A (de)
AU1189670A (de)

Legal Events

Date Code Title Description
PL Patent ceased